Novel Coronavirus Pneumonia (COVID 19) clinical trials

Access comprehensive clinical trial information for Novel Coronavirus Pneumonia (COVID 19) through Pure Global AI's free database. This collection includes 602 clinical trials across multiple phases including N/A, Early Phase 1, Phase 4. Currently, 282 trials are actively recruiting participants.

Research for Novel Coronavirus Pneumonia (COVID 19) is being conducted in China, Pakistan, The People's Republic of China and 7+ other countries. Leading sponsors include Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 602 clinical trials studying Novel Coronavirus Pneumonia (COVID 19), aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Shanghai Public Health Clinical Center, among others.